Welcome to the ISPPD 2022 Meeting Calendar
To check the meeting times in your local time zone Click Here
54 Sessions
Session Type- 10 Options Selected
Filtered By
- 10 Options Selected
Legend
- Plenary Session (2) (2)
- Parallel Session (4) (4)
- Meet-the-Expert Session (3) (3)
- Break (4) (4)
- Poster Spotlight Session (1) (1)
Grand Ballroom East
Grand Ballroom Centre
Grand Ballroom West
Birchwood Ballroom
Exhibition Area
Station 01
- 09:00
- 10:00
- 11:00
- 12:00
- 13:00
- 14:00
- 15:00
- 16:00
- 17:00
-
Session TitleSession Time09:00 - 10:30RoomGrand Ballroom EastSession DescriptionPlease note: Each presentation is followed by 5 to 10 minutes of Q&A. The audience is encouraged to send questions to the speakers from the beginning of their presentations. Q&A time is included in each speaker’s presentation duration, accounting for at least 25% active learning for the maximum registrants anticipated.
-
Session TitleSession Time11:00 - 12:30RoomGrand Ballroom EastSession DescriptionPlease note: Each presentation is followed by 5 to 10 minutes of Q&A. The audience is encouraged to send questions to the speakers from the beginning of their presentations. Q&A time is included in each speaker’s presentation duration, accounting for at least 25% active learning for the maximum registrants anticipated.
-
Session TitleSession Time13:30 - 14:30RoomGrand Ballroom EastSession DescriptionIn this session, various approaches to measure carriage of S. pneumoniae and of pneumococcal serotypes will be discussed. After active participation, attendants will be able to: - Identify conventional and cutting edge methods for measuring pneumococcal carriage and pneumococcal serotypes; - Contrast the advantages and disadvantages of conventional culture-based and molecular-based methods - Select the best method to be used in specific contexts with emphasis on age of investigated individuals and available samples. Please note: All MTE sessions are designed to encourage active learning and to concentrate on close interaction between audience and speakers. The MTE session organisers have provided at least 15 minutes for active discussions in their agenda.
-
Session Time14:50 - 16:20RoomGrand Ballroom EastSession DescriptionPlease note: Each presentation is followed by about 3 minutes of Q&A. The audience is encouraged to send questions to the speakers from the beginning of their presentations. Q&A time is included in each speaker’s presentation duration, accounting for at least 25% active learning for the maximum registrants anticipated.
-
Session TitleSession Time13:30 - 14:30RoomGrand Ballroom CentreSession DescriptionPlease note: All MTE sessions are designed to encourage active learning and to concentrate on close interaction between audience and speakers. The MTE session organisers have provided at least 15 minutes for active discussions in their agenda.
-
Session Time14:50 - 16:20RoomGrand Ballroom CentreSession DescriptionPlease note: Each presentation is followed by about 3 minutes of Q&A. The audience is encouraged to send questions to the speakers from the beginning of their presentations. Q&A time is included in each speaker’s presentation duration, accounting for at least 25% active learning for the maximum registrants anticipated.
-
Session Time13:30 - 14:30RoomGrand Ballroom WestSession DescriptionIn this session we will present data from our respective countries on the main serotypes that are emerging to be dominant in the post higher valency vaccine use era (i.e. post 13vPCV/10vPCV) and discuss the interpretation of that data in terms of serotype replacement. We will touch on definitions and views on the possible mechanisms of serotype replacement. We will also focus on changes in serotype 3 disease, what effect COVID-19 pandemic would have had on serotype profile of pneumococcal disease and the place of new higher valency PCVs becoming available now (such as 15vPCV and 20vPCV) in addressing replacement disease. We believe that this session will help attendees in interpreting pneumococcal disease epidemiology following vaccine use and understand changes in serotype distribution in the context of replacement. There will be learnings from the data we will discuss that mainly reflect what occurred in countries with mature PCV programs for other settings that have introduced PCVs more recently and also those yet considering PCV use. Please note: All MTE sessions are designed to encourage active learning and to concentrate on close interaction between audience and speakers. The MTE session organisers have provided at least 15 minutes for active discussions in their agenda.
-
Session Time14:50 - 16:20RoomGrand Ballroom WestSession DescriptionPlease note: Each presentation is followed by about 3 minutes of Q&A. The audience is encouraged to send questions to the speakers from the beginning of their presentations. Q&A time is included in each speaker’s presentation duration, accounting for at least 25% active learning for the maximum registrants anticipated.
-
Session TitleSession Time14:50 - 16:20RoomBirchwood BallroomSession DescriptionPlease note: Each presentation is followed by about 3 minutes of Q&A. The audience is encouraged to send questions to the speakers from the beginning of their presentations. Q&A time is included in each speaker’s presentation duration, accounting for at least 25% active learning for the maximum registrants anticipated.
-
Session TitleSession Time10:30 - 11:00RoomExhibition Area
-
Session TitleSession Time12:30 - 13:30RoomExhibition Area
-
Session TitleSession Time16:20 - 16:50RoomExhibition Area
-
Session TitleSession Time16:50 - 17:50RoomStation 01Session DescriptionFor the programme scheduling, please click here